Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Altimmune Appoints Richard Menziuso as Vice President, Global Controller
On September 24, 2026, Altimmune, Inc. appointed Richard Menziuso as its Vice President, Global Controller, and Principal Accounting Officer. This appointment is effective as of September 29, 2026
Company Information
Company
Altimmune
Location
910 Clopper Rd
Gaithersburg, Maryland, United States
About
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity.
Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GaithersburgBiotechnologyHealth CareTherapeuticsBiopharmaresearch